相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
Thomas Sandmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma
Ulrik Lassen et al.
NEURO-ONCOLOGY (2015)
MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma
Emeline Tabouret et al.
NEURO-ONCOLOGY (2015)
Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects
Tracy T. Batchelor et al.
CLINICAL CANCER RESEARCH (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity
Belén Mezquita et al.
Cells (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Kan V. Lu et al.
CANCER CELL (2012)
VEGF Exerts an Angiogenesis-Independent Function in Cancer Cells to Promote Their Malignant Progression
Ying Cao et al.
CANCER RESEARCH (2012)
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
Petra Hamerlik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay - A comparative study
Karl Buch et al.
RADIATION ONCOLOGY (2012)
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
Kei Okatsu et al.
NATURE COMMUNICATIONS (2012)
VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth
Natasha Y. Frank et al.
CANCER RESEARCH (2011)
Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
Jenny Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Carlos Bais et al.
CELL (2010)
VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis
Luqing Zhang et al.
CELL RESEARCH (2010)
Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1
Chris Folkins et al.
CANCER RESEARCH (2009)
The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes
Vadim Tchaikovski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Flt-1 signaling in macrophages promotes glioma growth in vivo
Mark Kerber et al.
CANCER RESEARCH (2008)
Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay
Petra Knizetova et al.
CELL CYCLE (2008)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting
Qi Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration
Benoit Favier et al.
BLOOD (2006)
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments
Maria Grazia Lampugnani et al.
JOURNAL OF CELL BIOLOGY (2006)
Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models
L Xu et al.
CANCER RESEARCH (2006)
Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid
MFW Gee et al.
ONCOGENE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3
S Tanno et al.
LUNG CANCER (2004)
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites
J Dixelius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
M Autiero et al.
NATURE MEDICINE (2003)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet et al.
NATURE MEDICINE (2001)
分享论文
